Phenotypic characteristics of colorectal cancer in BRCA1/2 mutation carriers

被引:11
|
作者
Grinshpun, Albert [1 ]
Halpern, Naama [2 ,5 ]
Granit, Roy Zvi [3 ]
Hubert, Ayala [1 ]
Hamburger, Tamar [1 ]
Laitman, Yael [4 ,5 ]
Shacham-Shmueli, Einat [2 ,5 ]
Peerless, Yehudit [1 ]
Friedman, Eitan [4 ,5 ]
Peretz, Tamar [1 ]
机构
[1] Hadassah Hebrew Univ, Med Ctr, Sharett Inst Oncol, Jerusalem, Israel
[2] Chaim Sheba Med Ctr, Inst Oncol, Ramat Gan, Israel
[3] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, Jerusalem, Israel
[4] Chaim Sheba Med Ctr, Susanne Levy Gertner Oncogenet Unit, Ramat Gan, Israel
[5] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
关键词
CONSENSUS MOLECULAR SUBTYPES; FOUNDER MUTATIONS; BREAST; RISKS;
D O I
10.1038/s41431-017-0067-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutations in the BRCA1/2 genes were recently shown to be associated with an increased risk for colorectal cancer. We characterized the largest cohort available of BRCA1/2 mutation carriers with colorectal cancer. We analyzed 32 patients with lower gastrointestinal cancers and germline BRCA1/2 mutations from two large academic hospital registries; 91% of patients were of Ashkenazi ancestry, 78% were women, and 62.5% were carriers of BRCA1 gene mutations. A high percentage of colorectal tumors (34.5%) had a mucinous histology and were located atypically in the left colon. Two patients had anal cancer with unusual histology and an additional patient had mucinous small bowel carcinoma. Gene expression analysis showed significant correlation between the gene signatures of left mucinous colorectal cancer and basal-like breast cancer. Our results imply that Ashkenazi BRCA1/2 mutation carriers with colorectal cancer might have unique characteristics with a high rate of left-sided, mucinous histology colorectal cancer, and possibly anal carcinoma. This report suggests a phenotypic influence of defects in DNA repair genes on colorectal tumors.
引用
收藏
页码:382 / 386
页数:5
相关论文
共 50 条
  • [41] Pregnancy after breast cancer in BRCA1/2 mutation carriers
    Jelena Maksimenko
    Arvīds Irmejs
    Jānis Gardovskis
    Hereditary Cancer in Clinical Practice, 20
  • [42] Breast cancer growth rates in BRCA1/2 mutation carriers
    Bosse, K.
    Gossmann, A.
    Rhiem, K.
    Warm, M.
    Schmutzler, R. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [43] Appendectomy and cancer risk in Jewish BRCA1 and BRCA2 mutation carriers
    Bernholtz, Shiri
    Jakobson-Setton, Ariella
    Korach, Jacob
    Ben Baruch, Gilad
    Laitman, Yael
    Friedman, Eitan
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 131 (03) : 981 - 985
  • [44] Pregnancy after breast cancer in BRCA1/2 mutation carriers
    Maksimenko, Jelena
    Irmejs, Arvids
    Gardovskis, Janis
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2022, 20 (01)
  • [45] Risk of uterine cancer in BRCA1 and BRCA2 mutation carriers.
    Lee, Yeh Chen
    Milne, Roger L.
    Smith, Charmaine
    Picken, Sandra
    Camm, Stephanie
    McLachlan, Sue-Anne
    Friedlander, Michael
    Hopper, John L.
    Phillips, Kelly-Anne
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [46] Conservative Management of Breast Cancer in BRCA1/2 Mutation Carriers
    Garcia-Etienne, C. A.
    Barile, M.
    Gentilini, O. D.
    Botteri, E.
    Rotmensz, N.
    Farante, G.
    Luini, A.
    Bonanni, B.
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 : 3 - 4
  • [47] Genetic modifiers of cancer risk for BRCA1 and BRCA2 mutation carriers
    Milne, R. L.
    Antoniou, A. C.
    ANNALS OF ONCOLOGY, 2011, 22 : i11 - i17
  • [48] Appendectomy and cancer risk in Jewish BRCA1 and BRCA2 mutation carriers
    Shiri Bernholtz
    Ariella Jakobson-Setton
    Jacob Korach
    Gilad Ben Baruch
    Yael Laitman
    Eitan Friedman
    Breast Cancer Research and Treatment, 2012, 131 : 981 - 985
  • [49] Survival of breast cancer in BRCA1 and BRCA2 carriers versus non-carriers: mutation analysis and tumour characteristics
    Schmidt, M. K.
    Tollenaar, R. A. E. M.
    van Leeuwen, F. E.
    van't Veer, L. J.
    EJC SUPPLEMENTS, 2004, 2 (03): : 152 - 152
  • [50] Clinical characteristics of affected BRCA1 and BRCA2 mutation carriers in an underserved population
    El-Masry, M.
    Ricker, C.
    Spicer, D. V.
    Tripathy, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)